IMUPSORA TABLET

Indications

• Anxiety
• Stress-related disorders
• Insomnia
• Inflammatory conditions
• Pain management

Dosage

Children: Refer to herbal medicine guidelines for dosage. Consult a healthcare provider for age-appropriate dosing.

Adults: Refer to herbal medicine guidelines for dosage. Specific doses vary based on formulation and preparation.

Mechanism of action

The exact mechanism of action of Albizzia extracts is not fully elucidated. However, studies suggest that it may exert its effects through modulation of neurotransmitter systems, including the enhancement of GABAergic activity, which promotes relaxation and reduces anxiety. Additionally, the anti-inflammatory effects may be attributed to the inhibition of pro-inflammatory cytokines and pathways involved in oxidative stress.

Pharmacodynamics

Albizzia exhibits a range of pharmacodynamic effects including anxiolytic, sedative, and anti-inflammatory activities. Its anxiolytic properties are thought to stem from its ability to enhance GABA activity, thereby promoting calmness and reducing anxiety without significant sedation. The anti-inflammatory effects may help in alleviating symptoms associated with inflammatory conditions, although specific pathways and targets remain to be thoroughly characterized.

Pharmacokinetics

The pharmacokinetics of Albizzia are not well documented in clinical studies. However, it is generally assumed that the active compounds are absorbed through the gastrointestinal tract following oral administration. The time to peak plasma concentration, distribution, metabolism, and excretion of the compounds may vary depending on the specific alkaloids or flavonoids present. Data on half-life and bioavailability are limited, necessitating further research.

Pregnancy

Limited data is available on the safety of albizzia during pregnancy. Consult healthcare professionals before use.

Breast-feeding

There is insufficient information on the excretion of albizzia in human milk. Caution is advised when using during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Indications

• Pain relief
• Inflammation management
• Antioxidant support

Dosage

Children: Paediatric dosing is not well established; consult a healthcare professional or refer to specific product guidelines for safe use in children.

Adults: Dosage varies widely depending on the formulation and concentration of Beej. It is recommended to refer to specific product guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The exact mechanism of action of Beej is not well-documented in scientific literature. However, it is thought to exert its effects through modulation of inflammatory pathways and antioxidant activity, potentially involving the inhibition of pro-inflammatory cytokines and enhancement of endogenous antioxidant defenses.

Pharmacodynamics

Beej may have a range of pharmacodynamic effects based on its constituents. It is believed to provide relief from pain and inflammation, possibly by inhibiting cyclooxygenase enzymes and reducing the production of inflammatory mediators. Additionally, its antioxidant properties may help in protecting cells from oxidative stress.

Pharmacokinetics

Pharmacokinetic data specific to Beej is limited. Generally, the absorption, distribution, metabolism, and excretion of herbal products can vary widely based on their formulation and the individual's physiology. Most herbal formulations are absorbed in the gastrointestinal tract, and their effects may be influenced by factors such as formulation, dosage, and the presence of other substances.

Pregnancy

The safety of beej in pregnancy has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Beej is excreted in breast milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and light. Keep out of reach of children.

Indications

• Respiratory disorders
• Digestive issues
• Skin diseases
• Anemia
• General health and wellness

Dosage

Children: Paediatric dosing of bhasma is also variable and should be determined based on the child's age, weight, and specific health concerns. Consultation with a healthcare professional experienced in Ayurvedic medicine is advised.

Adults: Dosage for adults can vary widely based on the specific type of bhasma and the condition being treated. It is recommended to refer to traditional Ayurvedic guidelines or consult a qualified practitioner for specific dosing.

Mechanism of action

The exact mechanism of action of bhasma is not fully understood, but it is believed to involve the bioactive compounds released during the calcination process, which may exert antioxidant, anti-inflammatory, and immunomodulatory effects. These properties can enhance physiological functions and promote the healing processes in the body.

Pharmacodynamics

Bhasma exhibits various pharmacological effects, which may include modulation of immune responses, enhancement of metabolic functions, and promotion of detoxification processes. The bioavailability of minerals and metals in bhasma can lead to improved physiological activity, potentially affecting enzymatic activities and cellular signaling pathways.

Pharmacokinetics

Pharmacokinetic data specific to bhasma is limited due to its complex composition and traditional preparation methods. However, it is generally thought to be absorbed through the gastrointestinal tract when ingested, with its effects being dose-dependent. The elimination and metabolism of the components may vary based on individual physiology and the specific formulation of bhasma used.

Pregnancy

The safety of bhasma during pregnancy has not been well studied. It is advisable to consult a healthcare professional before use.

Breast-feeding

The excretion of bhasma in breast milk is not well documented. Caution is advised, and consultation with a healthcare professional is recommended.

Storage

Bhasma should be stored in a cool, dry place, away from direct sunlight and moisture, to maintain its potency and effectiveness.

Indications

• Constipation
• Skin disorders
• Detoxification
• Digestive health

Dosage

Children: Refer to established herbal guidelines and consult a healthcare professional for appropriate dosing.

Adults: Refer to established herbal guidelines and consult a healthcare professional for appropriate dosing.

Mechanism of action

Chakramarda primarily acts as a stimulant laxative. Its active compounds, including anthraquinones, stimulate peristalsis in the intestines, leading to increased bowel movements. The laxative effect is mediated through the irritation of the colonic mucosa, promoting fluid secretion and enhancing intestinal motility. Additionally, it may possess antimicrobial and anti-inflammatory properties, contributing to its therapeutic effects.

Pharmacodynamics

The pharmacodynamic effects of Chakramarda are attributed to its active ingredients, which include sennosides and flavonoids. These compounds enhance gastrointestinal motility and promote water retention in the intestines, thereby softening stools. The anti-inflammatory effects may also support its use in skin conditions. The onset of laxative action typically occurs within 6 to 12 hours after oral administration.

Pharmacokinetics

The pharmacokinetics of Chakramarda are not extensively studied. However, it is known that the active compounds are absorbed in the gastrointestinal tract, with some metabolites being excreted in urine. The elimination half-life of the active components is not clearly defined, and the overall bioavailability may vary based on the formulation and individual patient factors.

Adverse effects

• Gastrointestinal disturbances
• Allergic reactions
• Hypersensitivity
• Liver toxicity

Precautions

• Use with caution in patients with liver disease
• Monitor for signs of hypersensitivity
• Avoid in patients with known allergies to any component

Pregnancy

Limited data available; use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Limited data available; exercise caution and consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Powder
• Tablet
• Liquid extract

Indications

• Diabetes mellitus
• Diarrhea
• Gastrointestinal disorders
• Inflammatory conditions

Dosage

Children: Refer to established guidelines for specific dosages based on formulation and condition being treated.

Adults: Refer to established guidelines for specific dosages based on formulation and condition being treated.

Mechanism of action

Chhal contains several phytochemicals, including flavonoids and tannins, which are believed to exert their effects through mechanisms such as the modulation of glucose metabolism and enhancement of insulin sensitivity. These compounds may also demonstrate antioxidant properties, which help to mitigate oxidative stress in the body.

Pharmacodynamics

The pharmacodynamic effects of chhal include its potential to lower blood glucose levels, improve lipid profiles, and provide anti-inflammatory benefits. The astringent properties of chhal can also contribute to its gastrointestinal benefits, potentially aiding in the management of diarrhea and other digestive issues.

Pharmacokinetics

The pharmacokinetics of chhal have not been extensively studied in clinical settings. However, it is generally understood that the active components are absorbed in the gastrointestinal tract and distributed throughout the body, where they exert their therapeutic effects. The metabolism and excretion pathways of these compounds may vary depending on the specific constituents present in the preparation used.

Mechanism of action

The exact mechanism of action of galo is not well-documented in the available literature. However, it is suggested that it may interact with biochemical pathways related to isopropylamine metabolism, potentially influencing various physiological processes.

Pharmacodynamics

Pharmacodynamics details for galo are limited. The compound's effects may vary based on its biological interactions and the specific conditions it is used to treat. Understanding its pharmacodynamics would require additional research to elucidate its receptor binding, signaling pathways, and resultant physiological effects.

Pharmacokinetics

Information on the pharmacokinetics of galo, including its absorption, distribution, metabolism, and excretion, is not specified. This data is essential for understanding how the drug behaves in the human body and will be pivotal in determining dosing regimens and safety profiles.

Pregnancy

There are no well-controlled studies in pregnant women. Use only if clearly needed and the benefits outweigh the risks.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution should be exercised when administering to nursing women.

Storage

Store at room temperature, away from moisture and heat.

Indications

• Liver diseases (e.g., hepatitis, cirrhosis)
• Digestive disorders
• Anti-inflammatory conditions
• Immunomodulation
• Antioxidant support

Dosage

Children: Refer to established guidelines and consult with a healthcare professional for appropriate dosage, as specific dosing for children should be determined based on age, weight, and clinical condition.

Adults: Refer to established guidelines and consult with a healthcare professional for appropriate dosage, as specific dosing can vary based on the formulation and clinical indication.

Mechanism of action

The active compounds in katuki, particularly picroside I and picroside II, are believed to exert their effects through several mechanisms. They enhance liver function and bile secretion, promote the regeneration of liver cells, and possess antioxidant properties that protect against oxidative stress. Additionally, katuki has shown immunomodulatory effects, helping to regulate immune responses.

Pharmacodynamics

Katuki displays hepatoprotective effects, making it beneficial in conditions affecting liver health, such as hepatitis and liver cirrhosis. Its anti-inflammatory properties can help reduce inflammation in various conditions, while its antioxidant capabilities mitigate cellular damage caused by free radicals, contributing to overall health.

Pharmacokinetics

Limited pharmacokinetic data is available for katuki. However, it is known that the active constituents are metabolized in the liver and may exhibit variable bioavailability depending on the formulation and method of extraction. The elimination half-life and specific metabolic pathways have not been extensively studied.

Pregnancy

There is insufficient data on the safety of katuki during pregnancy. It is advisable to avoid use unless clearly needed and prescribed by a healthcare provider.

Breast-feeding

Limited information is available regarding the excretion of katuki in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store in a cool, dry place away from direct sunlight and out of reach of children.

Indications

• Diarrhea
• Dysentery
• Skin infections
• Inflammatory bowel disease
• Sore throat
• Mouth ulcers

Dosage

Children: Refer to established guidelines and consult with a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines and consult with a healthcare professional for appropriate dosing.

Mechanism of action

The active compounds in Khair, particularly catechins, exhibit antioxidant properties that can scavenge free radicals. These compounds may also inhibit the growth of certain bacteria and fungi, thereby exerting antimicrobial effects. Additionally, catechins can promote vasodilation and improve blood flow, contributing to their therapeutic effects.

Pharmacodynamics

Khair demonstrates a range of pharmacological effects, including anti-inflammatory, antimicrobial, and astringent actions. Its astringent properties make it effective in reducing secretions and promoting tissue contraction, which is beneficial in gastrointestinal disorders. The anti-inflammatory effects can help alleviate symptoms associated with inflammatory conditions.

Pharmacokinetics

The pharmacokinetics of Khair have not been extensively studied. However, it is believed that the active compounds are absorbed in the gastrointestinal tract and may undergo hepatic metabolism before exerting their systemic effects. The duration of action and elimination half-life are not well-defined and would depend on the specific formulation and route of administration.

Pregnancy

There is limited information on the safety of khair during pregnancy. It is advisable to avoid use unless the benefits outweigh potential risks.

Breast-feeding

Insufficient data is available regarding the use of khair during breastfeeding. Caution is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Ensure it is kept out of reach of children.

Indications

• Inflammation
• Pain relief
• Antioxidant support
• Traditional medicine applications

Dosage

Children: Refer to established herbal medicine dosing guidelines for specific usage in children. Doses should be determined by a qualified healthcare provider.

Adults: Refer to established herbal medicine dosing guidelines for specific usage. Doses may vary based on preparation and indication.

Mechanism of action

The primary mechanism of action of lebbeck is thought to involve the modulation of inflammatory pathways and the inhibition of pro-inflammatory cytokines. The flavonoids present in the plant may exert antioxidant effects, scavenging free radicals and reducing oxidative stress, which is linked to various chronic diseases. Additionally, some components may have analgesic properties, contributing to pain relief.

Pharmacodynamics

Pharmacodynamically, lebbeck exhibits anti-inflammatory, analgesic, and antioxidant properties. These actions are mediated through complex interactions with biological systems, including inhibition of cyclooxygenase and lipoxygenase pathways, which play a crucial role in the synthesis of inflammatory mediators. The plant may also enhance immune response, although the exact pathways are still being investigated.

Pharmacokinetics

The pharmacokinetics of lebbeck are not well-documented in the literature. However, like many herbal extracts, it is likely that the components are absorbed in the gastrointestinal tract, metabolized in the liver, and excreted via the kidneys. The bioavailability and half-life of its active ingredients can vary widely based on preparation methods and individual patient factors.

Pregnancy

There is limited data on the safety of lebbeck in pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

There is insufficient information on the excretion of lebbeck in human milk. Caution is advised when administered to a breastfeeding woman.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Skin disorders (e.g. eczema, psoriasis, acne)
• Wound healing
• Blood purification
• Liver support
• Anti-inflammatory conditions

Dosage

Children: Refer to established guidelines or consult a healthcare provider for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare provider for appropriate dosing.

Mechanism of action

Manjishtha exerts its effects primarily through its active constituents, particularly anthraquinones such as rubiadin and rubiaceous compounds. These compounds are believed to enhance blood circulation, possess anti-inflammatory and antioxidant properties, and support the detoxification processes in the liver. The herb is thought to modulate various biochemical pathways, contributing to its efficacy in treating skin conditions and supporting overall health.

Pharmacodynamics

The pharmacodynamics of manjishtha involve its ability to enhance microcirculation, promote lymphatic drainage, and modulate immune responses. Its anti-inflammatory properties help reduce swelling and redness in skin disorders, while its antioxidant action combats oxidative stress, which is a contributing factor in various skin ailments. Additionally, manjishtha supports the liver's functions, which is crucial for detoxification and metabolic processes.

Pharmacokinetics

The pharmacokinetics of manjishtha have not been extensively studied in clinical settings. However, it is generally understood that its active compounds are absorbed in the gastrointestinal tract and exhibit a systemic effect after metabolism. The elimination half-life and specific metabolic pathways remain largely uncharacterized due to the lack of rigorous clinical pharmacokinetic studies.

Adverse effects

• Gastrointestinal upset
• Skin rash or irritation
• Allergic reactions

Interactions

• May interact with anticoagulants or antiplatelet agents
• Possible effects on the metabolism of other drugs due to liver enzyme induction

Precautions

• Use with caution in patients with liver dysfunction
• Monitor for allergic reactions
• Consult healthcare provider before use in conjunction with other medications

Pregnancy

Use during pregnancy is not well-studied. Consult a healthcare provider.

Breast-feeding

Safety during breastfeeding has not been established. Consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powder
• Capsules
• Tinctures

Indications

• Liver disorders
• Digestive issues
• Anti-inflammatory conditions
• Antioxidant support

Dosage

Children: Refer to established guidelines and consult with a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines and consult with a healthcare professional for appropriate dosing.

Mechanism of action

The exact mechanism of action of pittapapada is not fully understood. However, it is believed to exert its effects through the modulation of various biochemical pathways, including the inhibition of pro-inflammatory cytokines and the promotion of antioxidant defense mechanisms. Several studies suggest that it may enhance liver function and protect against oxidative stress.

Pharmacodynamics

Pittapapada demonstrates a variety of pharmacodynamic effects, such as hepatoprotection, anti-inflammatory actions, and the ability to scavenge free radicals. These effects contribute to its traditional use in managing liver disorders and other related conditions. The bioactive compounds in pittapapada may influence metabolic processes and enhance detoxification pathways in the liver.

Pharmacokinetics

The pharmacokinetics of pittapapada are not well-documented due to limited studies. However, it is known that the active compounds are likely absorbed through the gastrointestinal tract after oral administration. The metabolism and elimination pathways are not well characterized, which complicates the understanding of its bioavailability and systemic effects. Further research is needed to clarify these aspects.

Pregnancy

The safety of pittapapada during pregnancy has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether pittapapada is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Skin disorders
• Respiratory issues
• Digestive problems
• Anti-inflammatory conditions
• Antimicrobial applications

Dosage

Children: Refer to established herbal guidelines as specific dosing for Sariva is not standardized.

Adults: Refer to established herbal guidelines as specific dosing for Sariva is not standardized.

Mechanism of action

The exact mechanism of action of Sariva is not fully elucidated; however, it is thought to exert its effects through the modulation of various biological pathways. It contains compounds such as flavonoids and saponins, which may contribute to its anti-inflammatory and antimicrobial effects by inhibiting pro-inflammatory cytokines and promoting antioxidant activity.

Pharmacodynamics

Sariva exhibits a range of pharmacodynamic effects, including anti-inflammatory, antioxidant, and immunomodulatory actions. These effects may help in the management of inflammatory conditions, enhancing the body's immune response, and protecting against oxidative stress. The plant is also thought to have a mild diuretic effect, which may contribute to its traditional uses in promoting detoxification and improving urinary health.

Pharmacokinetics

The pharmacokinetics of Sariva have not been extensively studied in clinical settings. However, it is known that the bioactive compounds within Sariva are likely absorbed in the gastrointestinal tract after oral administration. The metabolism and elimination pathways remain unclear, and further studies are warranted to understand its pharmacokinetic profile fully.

Pregnancy

Safety in pregnancy has not been established. Use only if clearly needed.

Breast-feeding

It is not known if this drug is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Constipation
• Digestive disorders
• Detoxification
• Antioxidant support
• Immune enhancement

Dosage

Children: For children, it is advisable to consult a healthcare professional for appropriate dosing recommendations, as specific pediatric doses may vary based on age and condition.

Adults: General guidance suggests starting with 1-2 teaspoons of triphala powder mixed in warm water, taken once or twice daily. For specific dosing, refer to established guidelines.

Mechanism of action

The mechanism of action of triphala is attributed to its rich polyphenolic content, vitamins, and minerals. It exhibits antioxidant activity by scavenging free radicals, thus reducing oxidative stress. Additionally, triphala has been shown to modulate gut microbiota, improve digestion, and promote regular bowel movements by enhancing peristalsis. It may also possess anti-inflammatory properties that contribute to its therapeutic effects.

Pharmacodynamics

Triphala demonstrates a variety of pharmacodynamic effects. Its components exhibit laxative properties, which help alleviate constipation. Amla is known for its high vitamin C content and immune-boosting effects, while haritaki is recognized for its digestive and detoxifying properties. The combined action of these fruits provides a synergistic effect, enhancing gastrointestinal function and supporting overall health.

Pharmacokinetics

The pharmacokinetics of triphala have not been extensively studied in clinical settings. However, it is generally believed that the absorption and bioavailability of its active constituents occur in the gastrointestinal tract. The metabolites exert their effects locally within the gut, while some components may enter systemic circulation, contributing to their antioxidant and anti-inflammatory activities. The elimination pathway is primarily through the gastrointestinal tract.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Abdominal cramping
• Nausea

Interactions

• May enhance the effects of anticoagulants
• May affect the absorption of other medications due to its laxative effects

Precautions

• Use with caution in patients with gastrointestinal disorders
• Patients on anticoagulant therapy should consult a healthcare provider before use

Pregnancy

Consult a healthcare provider before use, as safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare provider before use, as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powder
• Capsules
• Tablets
• Liquid extract

Indications

• Severe infections caused by Gram-positive bacteria
• Methicillin-resistant Staphylococcus aureus (MRSA) infections
• Endocarditis
• Osteomyelitis
• Skin and soft tissue infections
• Pneumonia caused by MRSA
• Clostridium difficile infection (oral administration)

Dosage

Children: Refer to

Adults: Refer to the BNF for specific dosing guidelines based on the type and severity of infection.

Mechanism of action

Vancomycin works by inhibiting bacterial cell wall synthesis. It binds to the D-alanyl-D-alanine terminus of the cell wall precursor units, preventing their incorporation into the growing cell wall. This action disrupts the integrity of the bacterial cell wall, leading to cell lysis and death. Vancomycin is particularly effective against dividing bacteria that are actively synthesizing their cell walls.

Pharmacodynamics

The pharmacodynamics of vancomycin involve its time-dependent killing properties, meaning that the efficacy of the drug is related to the duration of time that serum concentrations exceed the minimum inhibitory concentration (MIC) for the target organism. The drug exhibits bactericidal activity against susceptible organisms, particularly against staphylococci and enterococci. Resistance can develop, particularly with enterococci, if vancomycin is used inappropriately.

Pharmacokinetics

Vancomycin is poorly absorbed from the gastrointestinal tract, which is why oral formulations are used primarily for localized infections like C. difficile. When administered intravenously, it distributes widely into body tissues and fluids. The volume of distribution is approximately 0.4 to 1 L/kg. Vancomycin is primarily eliminated by the kidneys, with a half-life ranging from 4 to 6 hours in individuals with normal renal function. Dosage adjustments may be necessary in patients with renal impairment.

Pregnancy

Data on the use of Vang in pregnancy is limited. It is advisable to use caution and consult healthcare professionals before use.

Breast-feeding

Information on the excretion of Vang in breast milk is not well established. Caution is advised when administering to breastfeeding mothers.

Storage

Store in a cool, dry place away from direct sunlight.